Cargando…
Association between plasma PCSK9 levels and lipid profile in patients with Parkinson’s disease and comparison with healthy subjects
Background: Up to know, limited and contradictory results have been published about the role of prognostic values of lipid profile and proprotein convertase subtilisin/kexin type 9 (PCSK9) in Parkinson’s disease (PD). The aim of the present study is to investigate the role of lipid profile and PCSK9...
Autores principales: | Jahed, Mohammad Reza, Habibi, Seyed Amir Hassan, Vaseghi, Golnaz, Amiri, Hasan, Montazeri, Hamed, Eshraghi, Azedeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189203/ https://www.ncbi.nlm.nih.gov/pubmed/38011467 http://dx.doi.org/10.18502/cjn.v21i4.11721 |
Ejemplares similares
-
PCSK9 and Atherosclerosis - Lipids and Beyond
por: Shapiro, Michael D., et al.
Publicado: (2017) -
Association of Polymorphism of Ser311cys Paraoxonase-2 Gene with Type 2 Diabetes Mellitus in Iran
por: Andalib, Sasan, et al.
Publicado: (2013) -
PCSK9 targets important for lipid metabolism
por: Schulz, Rainer, et al.
Publicado: (2017) -
FOURIER & PCSK9 RNAi: Towards enhancing durability and efficacy of PCSK9 inhibitors
por: Hassan, Mohamed
Publicado: (2017) -
Ramadan Intermittent Fasting Is Associated with Changes in Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Metabolically Healthy Obese Subjects
por: Hasan, Hayder, et al.
Publicado: (2022)